US FDA assent for 4D Medical’s CT VQ ventilation perfusion device described by the company as a “transformational milestone”.

Let's take a look at some up and coming tech stars on the ASX. Australia's tech landscape is quietly emerging with innovative ASX stocks poised to achieve global recognition amidst dominant mining and ...

A respiratory imaging company's shares fell 11% due to profit-taking after significant gains from receiving U.S. FDA clearance for a key product, although they remain significantly up over the past ...

Editor’s note: Capnography is one of the most powerful tools in the EMS toolbox. It tells us what’s happening with a patient’s ventilation, perfusion and metabolism — instantly and continuously. But ...

After five months of consecutive gains the ASX 200 fell 0.78% in September with nine of 11 sectors in the red.